Heterozygous Tumor Suppressor Microenvironment in Cancer Development

被引:8
|
作者
Brosseau, Jean-Philippe [1 ]
Le, Lu Q. [1 ,2 ,3 ,4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, UTSW Comprehens Neurofibromatosis Clin, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA
来源
TRENDS IN CANCER | 2019年 / 5卷 / 09期
基金
美国国家卫生研究院;
关键词
NF1; GLIOMA; CELLS; PROGRESSION; MICROGLIA; ASTROCYTE; ORIGIN; GROWTH; STAT3;
D O I
10.1016/j.trecan.2019.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hereditary cancer syndromes are typically caused by mutations of a tumor suppressor gene that lead to the early development of multifocal benign neoplasms followed by their malignant progression. However, the term 'hereditary cancer syndrome' may be misleading, as a large subgroup of syndromes are characterized by highly penetrant benign tumors. The reason why these cardinal tumors rarely progress to malignancy has been an elusive question in cancer biology. In this opinion article, we propose a framework where a heterozygous tumor suppressor gene microenvironment has antagonistic roles in tumorigenesis, by accelerating development of benign tumors while restraining further progression to malignant cancers.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 50 条
  • [21] LncRNA LET function as a tumor suppressor in breast cancer development
    Zhou, C. -X.
    Wang, X.
    Yang, N.
    Xue, S. -K.
    Li, W. -C.
    Xie, P. -P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (18) : 6002 - 6007
  • [22] The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer
    Simon-Carrasco, Lucia
    Jimenez, Gerardo
    Barbacid, Mariano
    Drosten, Matthias
    CELL CYCLE, 2018, 17 (06) : 702 - 711
  • [23] Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer Development
    Messex, Justin K.
    Byrd, Crystal J.
    Liou, Geou-Yarh
    CELLS, 2020, 9 (04)
  • [24] Exploiting the tumor microenvironment in the development of targeted cancer gene therapy
    G J Dougherty
    S T Dougherty
    Cancer Gene Therapy, 2009, 16 : 279 - 290
  • [25] Editorial: Complexity of tumor microenvironment: A major culprit in cancer development
    Bukhari, Ihtisham
    Zhang, Yuanwei
    Thorne, Rick Francis
    Mi, Yang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Exploiting the tumor microenvironment in the development of targeted cancer gene therapy
    Dougherty, G. J.
    Dougherty, S. T.
    CANCER GENE THERAPY, 2009, 16 (03) : 279 - 290
  • [27] Novel immunotherapy for intractable pancreatic cancer focusing on the myeloid derived suppressor cells in the tumor microenvironment
    Tsuchikawa, Takahiro
    Takeuchi, Shintaro
    Nakamura, Toru
    Takahashi, Mizuna
    Inoko, Kazuho
    Kushibiki, Toshihiro
    Hontani, Koji
    Ono, Masato
    Kuwabara, Shota
    Shichinohe, Toshiaki
    Hirano, Satoshi
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [28] Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
    Li, Shiqi
    Long, Xinghua
    MEDCOMM, 2024, 5 (07):
  • [29] Characterizing myeloid-derived suppressor cells in the tumor microenvironment of colorectal cancer FFPE samples
    Vasaturo, Angela
    Patel, Katir
    Manesse, Mael
    Downing, Sean
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy
    Yin, Zhongnan
    Li, Chunxiao
    Wang, Junjie
    Xue, Lixiang
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 933 - 946